Mirabegron
Shop Mirabegron on KimeraChems · code GUIDE (10% off)Definition
Mirabegron is a beta-3 adrenergic receptor agonist researched for its ability to modulate sympathetic signaling in target tissues. In research contexts, it is primarily explored for its effects on detrusor smooth-muscle relaxation and urinary-storage dynamics through beta-3 receptor activation, as well as for its broader downstream effects on cyclic adenosine monophosphate (cAMP) signaling in responsive models. Because beta-adrenergic signaling can influence multiple organ systems, Mirabegron is also investigated in metabolic and cardiovascular research designs in which adrenergic tone is a controlled variable.
Available Formats
- 30 mL liquid solution (100 mg per mL / 3 g total)
- 5 grams powder
Mechanism of Action
Research suggests Mirabegron may
- Activate beta-3 adrenergic receptors in target tissues
- Increase intracellular cAMP signaling downstream of beta-3 activation
- Reduce detrusor contractility and support bladder relaxation during storage-phase models
- Alter autonomic signaling in study designs assessing urinary urgency and frequency endpoints
- Influence metabolic signaling in select models in which beta-3 activation is linked to thermogenesis and lipolysis pathways
Areas of Investigation
Mirabegron is commonly studied in
- Overactive-bladder and detrusor-overactivity research models
- Urodynamic studies involving bladder-capacity and urgency-related endpoints
- Autonomic-nervous-system modulation research
- Metabolic studies exploring beta-3-mediated energy-expenditure pathways
- Combination studies in which adrenergic signaling is paired with other metabolic variables
- Safety and tolerability profiling focused on heart-rate and blood-pressure endpoints
Safety Profile
Reported observations include
- Increased heart rate and elevated blood-pressure signals in sensitivity-prone models
- Headache-like effects
- Dry mouth or mild gastrointestinal discomfort
- Sleep disruption or stimulation-like effects in subjects with greater adrenergic sensitivity
- Urinary-retention-related risk signals as a conservative monitoring consideration in designs involving outlet-obstruction variables
- Drug-metabolism interaction signals in studies evaluating enzyme-inhibition effects
Interaction Notes
Mirabegron is often explored alongside variables that influence adrenergic tone, urinary function, or metabolic endpoints
For educational purposes only. Not for human consumption.